The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Since 2007 they have alerted residents of Pedreras of health damage Sep 17, 2021
- Chile turns the page on the second wave of coronavirus with benefits for those vaccinated Jul 15, 2021
- An Israeli study says the South African alternative can ‘penetrate’ Pfizer vaccine protection, but the vaccine is very effective Apr 19, 2021
- Named products that are not to be heated in the microwave Jun 5, 2020
- Pandemic coronavirus: information about COVID-19 as at 12 APR Apr 12, 2020
- Scientists have found what masks from the coronavirus are the most effective Jul 1, 2020
- Bob Odenkirk returns to work after hospitalization Sep 8, 2021